Susquehanna International Securities, Ltd. Galapagos Nv Put Options Transaction History

Susquehanna International Securities, Ltd.

$389 Million
Q3 2024

Put Options

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $786,500 - $1.51 Million	5,500 Added 100.0%	11,000 $2.16 Million
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $1.17 Million - $1.35 Million	-10,500 Reduced 65.63%	5,500 $709,000
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $851,295 - $1.12 Million	9,500 Added 146.15%	16,000 $1.88 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $570,765 - $719,225	6,500 New	6,500 $596,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

Bvf Inc San Francisco, CA

1.57M
Shares

$45.2 Million
1.44% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.41M
Shares

$40.6 Million
0.76% of portfolio
Prosight Management, LP Dallas, TX

1.03M
Shares

$29.6 Million
7.95% of portfolio
Logos Global Management LP San Francisco, CA

800K
Shares

$23 Million
3.05% of portfolio
Primecap Management CO Pasadena, CA

720K
Shares

$20.7 Million
0.02% of portfolio

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.

Account